These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 21420504)

  • 41. Antifungal prophylaxis for severely neutropenic chemotherapy recipients: a meta analysis of randomized-controlled clinical trials.
    Bow EJ; Laverdière M; Lussier N; Rotstein C; Cheang MS; Ioannou S
    Cancer; 2002 Jun; 94(12):3230-46. PubMed ID: 12115356
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antifungal prophylaxis in adult stem cell transplantation and haematological malignancy.
    Slavin MA; Heath CH; Thursky KA; Morrissey CO; Szer J; Ling LM; Milliken ST; Grigg AP
    Intern Med J; 2008 Jun; 38(6b):468-76. PubMed ID: 18588520
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antifungal prophylaxis following reduced-intensity stem cell transplantation.
    Kami M; Murashige N; Tanaka Y; Narimatsu H
    Transpl Infect Dis; 2006 Dec; 8(4):190-202. PubMed ID: 17116132
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antifungal prophylaxis for invasive mycoses in high risk patients.
    Ullmann AJ; Cornely OA
    Curr Opin Infect Dis; 2006 Dec; 19(6):571-6. PubMed ID: 17075333
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antifungal therapy strategies in hematopoietic stem-cell transplant recipients: early treatment options for improving outcomes.
    Chandrasekar P; Ljungman PT
    Transplantation; 2008 Jul; 86(2):183-91. PubMed ID: 18645475
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antifungal management practices in liver transplant recipients.
    Singh N; Wagener MM; Cacciarelli TV; Levitsky J
    Am J Transplant; 2008 Feb; 8(2):426-31. PubMed ID: 18190655
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Importance of antifungal prophylaxis in patients who received a nonmyeloablative allogeneic PBSC transplant.
    Mossad SB; Avery RK; Bolwell BJ
    Clin Infect Dis; 2003 Jun; 36(11):1503-4; author reply 1504. PubMed ID: 12766853
    [No Abstract]   [Full Text] [Related]  

  • 48. Prophylactic fluconazole in liver transplant recipients.
    Singh N; Yu VL
    Ann Intern Med; 2000 May; 132(10):843-4. PubMed ID: 10819716
    [No Abstract]   [Full Text] [Related]  

  • 49. [Antifungal prophylaxis in the postoperative period of lung transplant surgery in Spain].
    Sacanell J; Rey T; López E; Vicente R; Ballesteros MA; Iranzo R; Robles JC; Restrepo MI; Rello J;
    Med Intensiva; 2013 Apr; 37(3):201-5. PubMed ID: 23260267
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antifungal Prophylaxis in Liver Transplant Recipients.
    Winston DJ; Busuttil RW; Singh N
    Clin Infect Dis; 2015 Oct; 61(8):1349-50. PubMed ID: 26261207
    [No Abstract]   [Full Text] [Related]  

  • 51. HIV-positive to HIV-positive liver transplantation: To be continued.
    Lauterio A; Moioli MC; Di Sandro S; Travi G; De Carlis R; Merli M; Ferla F; Puoti M; De Carlis L
    J Hepatol; 2019 Apr; 70(4):788-789. PubMed ID: 30049545
    [No Abstract]   [Full Text] [Related]  

  • 52. Role of ketoconazole in renal transplant recipients.
    Udgiri NR; Mettu SR
    Transplantation; 2005 Jan; 79(2):252. PubMed ID: 15665783
    [No Abstract]   [Full Text] [Related]  

  • 53. Invasive mycoses in organ transplant recipients: controversies in prophylaxis and management.
    Singh N
    J Antimicrob Chemother; 2000 Jun; 45(6):749-55. PubMed ID: 10837425
    [No Abstract]   [Full Text] [Related]  

  • 54. The issue of the antifungal drug choice in prophylaxis of invasive fungal infection after liver transplant.
    Lavezzo B; Romagnoli R; Balagna R; De Rosa FG
    Transpl Infect Dis; 2020 Feb; 22(1):e13220. PubMed ID: 31782237
    [No Abstract]   [Full Text] [Related]  

  • 55. Echinocandins for antifungal prophylaxis in liver transplant recipients: Advance in the field or variation on a theme?
    Koval C
    Liver Transpl; 2016 Apr; 22(4):396-8. PubMed ID: 26899901
    [No Abstract]   [Full Text] [Related]  

  • 56. Prophylaxis of fungal infections in transplant patients.
    Abdala E; Costa SF; Strabelli TM; Pierrotti LC; Caramori ML; Azevedo LS; Ibrahim KY; Dulley FL; Varkulja GF; Castro Junior Gd; Almeida GM; Marques HH; Shikanai-Yasuda MA;
    Clinics (Sao Paulo); 2012; 67(6):681-4. PubMed ID: 22760912
    [No Abstract]   [Full Text] [Related]  

  • 57. Liver transplantation in man. The significance, patterns, and control of infection.
    Murray-Lyon IM; Evans DB; Foster WD; Holden RJ; Rake MO; Stern H; Calne RY; Williams R
    Br J Surg; 1970 Apr; 57(4):280-4. PubMed ID: 4985576
    [No Abstract]   [Full Text] [Related]  

  • 58. Hepatic spindle cell tumors in HIV positive children.
    Levin TL; Adam HM; van Hoeven KH; Goldman HS
    Pediatr Radiol; 1994; 24(1):78-9. PubMed ID: 8008509
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Antifungal prophylaxis in HIV-seropositive liver transplant recipients].
    Pozo Laderas JC
    Rev Iberoam Micol; 2011; 28(4):183-90. PubMed ID: 21420504
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prospective interventional study to evaluate the efficacy and safety of liposomal amphotericin B as prophylaxis of fungal infections in high-risk liver transplant recipients.
    Castroagudín JF; Pontón C; Bustamante M; Otero E; Martínez J; Tomé S; Conde R; Segade FR; Delgado M; Brage A; Galbán C; Varo E
    Transplant Proc; 2005 Nov; 37(9):3965-7. PubMed ID: 16386598
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.